BASF Venture Capital invests in North American investment fund ARCH Venture Fund VII
"ARCH is one of the most-respected venture capital funds in the U.S., supported by an impressive management team. ARCH will complement our strategy of investing in innovative companies that are active in BASF Group's five growth clusters - energy management, raw material change, nanotechnology plant biotechnology and white (industrial) biotechnology," said Keith Gillard, Principal of BASF Venture Capital America.
In addition, BASF will benefit from ARCH's excellent network of more than fifty North American universities and national laboratories. This will allow BASF Venture Capital to gain information about new technology trends and attractive potential investments at an early stage.
Other news from the department business & finance
These products might interest you
Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes by Gilson
Grab the Gilson pipettes with your name and favorite colors!
Customise Your Pipettes to Fit Your Research
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.